APR 10 (Otezla 10 mg)
Generic Name: apremilast
Pill with imprint APR 10 is Pink, Four-sided and has been identified as Otezla 10 mg. It is supplied by Celgene Corporation.
Otezla is used in the treatment of psoriatic arthritis; plaque psoriasis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Otezla 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for APR 10
Otezla
- Generic Name:
- apremilast
- Imprint:
- APR 10
- Strength:
- 10 mg
- Color:
- Pink
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Antirheumatics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Celgene Corporation
- National Drug Code (NDC):
- 59572-0630
More about Otezla (apremilast)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 231 Reviews – Add your own review/rating
- Drug class: antirheumatics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
